Related Experiment Videos
Spinal effects of alpha-endorphin in mice
Polish Journal of Pharmacology and Pharmacy
|September 1, 1986
Summary
Intracerebroventricular or intrathecal alpha-endorphin (alpha-E) injection in mice produced pain relief. Alpha-E induced antinociception at the spinal level via opioid receptors, but only inhibited locomotor activity when administered centrally.
Area of Science:
- Neuroscience
- Pharmacology
- Pain Research
Background:
- Alpha-endorphin (alpha-E) is an endogenous opioid peptide with known analgesic properties.
- Understanding the differential effects of central versus spinal administration of alpha-E is crucial for pain management strategies.
Purpose of the Study:
- To investigate the distinct antinociceptive and locomotor effects of intracerebroventricular (icv) versus intrathecal (ith) administration of alpha-endorphin in mice.
- To determine the role of opioid receptors in mediating these effects.
Main Methods:
- Male R-3 mice were administered alpha-endorphin (10 ng icv; 1 or 10 ng ith).
- Antinociceptive activity was assessed using the tail immersion test.
- Locomotor activity was measured using photocell actometers.
- The effects of naloxone, an opioid antagonist, were evaluated.
Main Results:
- Both icv and ith administration of alpha-E produced significant antinociception, which was reversed by naloxone.
- Locomotor activity was inhibited by icv alpha-E but not by ith alpha-E.
- Naloxone did not alter the effects of alpha-E on locomotor activity.
Conclusions:
- Exogenous alpha-endorphin exhibits differential effects depending on the route of administration (icv vs. ith).
- Alpha-endorphin induces spinal antinociception through opioid receptors.
- Central administration of alpha-E affects locomotor activity independently of opioid receptor activation.